VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Oral clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oral clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.
Oral clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome. J Clin Oncol. 2010 Jun 01; 28(16):2755-60.
View in:
PubMed
subject areas
Adenine Nucleotides
Administration, Oral
Age Factors
Aged
Aged, 80 and over
Antineoplastic Agents
Arabinonucleosides
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Kaplan-Meier Estimate
Male
Maximum Tolerated Dose
Middle Aged
Myelodysplastic Syndromes
Probability
Prognosis
Prospective Studies
Risk Assessment
Survival Analysis
Time Factors
Treatment Outcome
authors with profiles
WILLIAM K PLUNKETT JR
HAGOP M KANTARJIAN
VARSHA V GANDHI
ZEEV ESTROV
JORGE E CORTES
FARHAD RAVANDI-KASHANI
GUILLERMO GARCIA-MANERO
GAUTAM BORTHAKUR